Cite
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
MLA
Ross, Douglas D., et al. “Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines.” JNCI: Journal of the National Cancer Institute, vol. 91, no. 5, Mar. 1999, pp. 429–33. EBSCOhost, https://doi.org/10.1093/jnci/91.5.429.
APA
Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., Doyle, L. A., Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P., & Doyle, L. A. (1999). Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. JNCI: Journal of the National Cancer Institute, 91(5), 429–433. https://doi.org/10.1093/jnci/91.5.429
Chicago
Ross, Douglas D., Weidong Yang, Lynne V. Abruzzo, William S. Dalton, Erasmus Schneider, Hermann Lage, Manfred Dietel, et al. 1999. “Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell Lines.” JNCI: Journal of the National Cancer Institute 91 (5): 429–33. doi:10.1093/jnci/91.5.429.